Trade Viracta Therapeutics, Inc. - VIRX CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.05 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.02629% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.004068% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 0.46 |
| Open | 0.46 |
| 1-Year Change | -69.54% |
| Day's Range | 0.46 - 0.47 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Jul 25, 2024 | 0.46 | -0.05 | -9.80% | 0.51 | 0.51 | 0.46 |
| Jul 24, 2024 | 0.51 | 0.05 | 10.87% | 0.46 | 0.51 | 0.45 |
| Jul 23, 2024 | 0.47 | -0.01 | -2.08% | 0.48 | 0.48 | 0.46 |
| Jul 22, 2024 | 0.49 | -0.01 | -2.00% | 0.50 | 0.51 | 0.48 |
| Jul 19, 2024 | 0.53 | -0.01 | -1.85% | 0.54 | 0.55 | 0.53 |
| Jul 18, 2024 | 0.53 | 0.00 | 0.00% | 0.53 | 0.54 | 0.51 |
| Jul 17, 2024 | 0.53 | 0.00 | 0.00% | 0.53 | 0.55 | 0.52 |
| Jul 16, 2024 | 0.53 | 0.01 | 1.92% | 0.52 | 0.53 | 0.51 |
| Jul 15, 2024 | 0.51 | -0.01 | -1.92% | 0.52 | 0.53 | 0.51 |
| Jul 12, 2024 | 0.51 | 0.01 | 2.00% | 0.50 | 0.51 | 0.50 |
| Jul 11, 2024 | 0.48 | 0.00 | 0.00% | 0.48 | 0.50 | 0.47 |
| Jul 10, 2024 | 0.47 | 0.00 | 0.00% | 0.47 | 0.48 | 0.47 |
| Jul 9, 2024 | 0.47 | 0.01 | 2.17% | 0.46 | 0.49 | 0.46 |
| Jul 8, 2024 | 0.46 | -0.01 | -2.13% | 0.47 | 0.47 | 0.44 |
| Jul 5, 2024 | 0.45 | 0.02 | 4.65% | 0.43 | 0.45 | 0.43 |
| Jul 3, 2024 | 0.46 | 0.00 | 0.00% | 0.46 | 0.48 | 0.46 |
| Jul 2, 2024 | 0.47 | -0.06 | -11.32% | 0.53 | 0.53 | 0.47 |
| Jul 1, 2024 | 0.49 | -0.01 | -2.00% | 0.50 | 0.53 | 0.49 |
| Jun 28, 2024 | 0.53 | -0.02 | -3.64% | 0.55 | 0.55 | 0.53 |
| Jun 27, 2024 | 0.54 | -0.01 | -1.82% | 0.55 | 0.55 | 0.54 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Viracta Therapeutics, Inc. Company profile
About Viracta Therapeutics Inc
Viracta Therapeutics, Inc., formerly Sunesis Pharmaceuticals, Inc., is a precision oncology company. The Company is focused on the development of new medicines targeting virus-associated malignancies. The Company conducts clinical trials for its combination product candidate as a therapy for the treatment of relapsed/refractory Epstein-Barr virus-positive lymphoma. The Company is conducting three clinical trials for its lead product candidate, Nana-val, in EBV+ lymphomas and solid tumors, including a Phase II registrational trial of Nana-val in EBV+ lymphomas. Its lead product candidate is an all-oral combination of nanatinostat. Its development pipeline also includes vecabrutinib, a clinical-stage non-covalent ITK/BTK inhibitor and VRx-510, a preclinical-stage PDK-1 inhibitor. Its novel synthetic lethality approach targets the EBV genome to enable the killing of the tumor cells by inducing the expression of certain viral kinase genes which in-turn activate an antiviral drug.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Viracta Therapeutics Inc revenues decreased from $120K to $0K. Net loss increased from $21.6M to $114.8M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Higher net loss reflects Research and development increase of 85% to $21.7M (expense), Stock-based Compensation in SGA increase from $530K to $3.4M (expense).
Equity composition
Common Stock $.0001 Par, $400M. auth., 04/11, 46,027,474 issd. Insiders own 6.84%. IPO: 9/05, 6M shs. @ $7 by LehmanBrothers. 02/11, 1-for-6 reverse stock split. Preferred Stock $.0001 Par, $10M. auth., 12/10, 0 issd.
| Industry: | Biotechnology & Medical Research (NEC) |
2533 S Coast Hwy 101
Suite 210
CARDIFF BY THE SEA
CALIFORNIA 92007
US
News
How to manage risk when trading
Learn what risk management is and find out how understanding about it could help you identify potential risks in your investment portfolio. Find out more.
06:57, 22 July 2024
ECB preview: lack of new data sees markets expecting a hold
Markets expect the ECB to keep rates unchanged in July but expectations for a September cut rise
13:13, 18 July 2024
What is an IPO and how does it work?
Learn about what an IPO is, why they are important, and how they work.
07:19, 10 July 2024
What are the biggest stock exchanges worldwide?
Discover the largest stock exchanges in the world by market capitalisation, including the Nasdaq Stock Market, the New York Stock Exchange and the London Stock Exchange.
12:44, 9 July 2024
Top ETFs
ETFs, or exchange-traded funds, offer traders a versatile gateway into the financial markets.
16:23, 8 July 2024
Lloyds forecast: will Lloyds share price return to £1? Third party data forecast
What’s next for Lloyds amid higher inflation and the start of a potential recessionary cycle in the UK?
14:00, 8 July 2024
RBNZ Preview: OCR expected to remain unchanged as central bank focuses on inflation
The Reserve Bank of New Zealand meets on Wednesday, July 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
13:25, 8 July 2024People also watch
Still looking for a broker you can trust?
Join the 630,000+ traders worldwide that chose to trade with Capital.com